Need professional-grade analysis? Visit stockanalysis.com
$1.45B
N/A
N/A
N/A
Nanobiotix (NBTX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $30.80, down 8.85% from the previous close.
Over the past year, NBTX has traded between a low of $3.15 and a high of $35.93. The stock has gained 835.0% over this period. It is currently 14.3% below its 52-week high.
Nanobiotix has a market capitalization of $1.45B.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Side-by-side comparison against top Healthcare peers.